Compare ENTA & RILY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENTA | RILY |
|---|---|---|
| Founded | 1995 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 303.8M | 349.8M |
| IPO Year | 2012 | 2014 |
| Metric | ENTA | RILY |
|---|---|---|
| Price | $10.94 | $3.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $21.83 | N/A |
| AVG Volume (30 Days) | 244.8K | ★ 842.2K |
| Earning Date | 11-24-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.93 | ★ 138.49 |
| EPS | N/A | ★ N/A |
| Revenue | $102,814,000.00 | ★ $967,599,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 16.48 | 15.38 |
| 52 Week Low | $10.01 | $3.49 |
| 52 Week High | $17.15 | $11.24 |
| Indicator | ENTA | RILY |
|---|---|---|
| Relative Strength Index (RSI) | 45.83 | 31.83 |
| Support Level | $10.01 | N/A |
| Resistance Level | $13.94 | $4.54 |
| Average True Range (ATR) | 0.80 | 0.30 |
| MACD | 0.08 | 0.03 |
| Stochastic Oscillator | 41.51 | 6.25 |
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.
BRC Group Holdings Inc is a diversified holding company offering a platform of businesses, including financial services (with complementary banking and wealth management businesses), telecom, retail, and investments in equity, debt, and venture capital. It serves retail, corporate, capital providers, and individual customers across different business lines. The Group reports its activities in seven reportable business segments: Capital Markets, Wealth Management, Lingo, magicJack, Marconi Wireless, UOL, and Consumer Products. Maximum revenue is generated from the Consumer Products segment, which offers mobile computing accessories and home furnishing products. Geographically, the Group derives its revenue from North America.